Heartware's (HTWR) implantable pump wins FDA panel backing
Tweet
Share
E-mailGet Alerts HTWR Hot Sheet
Join SI Premium – FREE
Heartware's (Nasdaq: HTWR) implantable pump wins FDA panel backing
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Real-world Leqembi study shows 82% of Alzheimer's patients stable
- Tempest Therapeutics plans in vivo CAR-T trial for late 2026
- NeOnc gets FDA manufacturing feedback for NEO212 tablet transition
Create E-mail Alert Related Categories
FDA, Hot FDA News, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
